Use of RAI for Thyroid Cancer Comes Under Scrutiny
Doctors may be increasingly using radioactive iodine inappropriately to treat early stage, low-risk thyroid cancer after surgery, contrary to the latest guidelines and with some evidence it will do more harm than good, according to a report from the University of Michigan.
Conversely, the study indicates that some patients with more clinically significant, higher-risk disease are not getting treated with radioactive iodine according to guidelines.
"Our study findings indicate there's variation in care, and that's suggestive that there is some provider uncertainty in regard to which patients actually need radioactive iodine," Haymart said in a phone interview.
ROUNDS: Women’s Health Strategies
for Service Line Growth and Quality
When: September 15, 2011
Register today for this live webcast from Bon Secours Richmond Health System
"For certain groups, radioactive iodine treatments are clearly beneficial, but for other groups, the patients are going to do well no matter what you do in regard to treatment, so the risk of using radioactive iodine really needs to be considered," said Megan R. Haymart, MD, author of the study.
"The recent guidelines (issued in 2009 by the American Thyroid Association) say those with very low risk disease don't need it, but there's a huge middle ground – a gray zone – where they leave it to the provider's discretion. So it's very possible that some of those patients don't need it as well."
- $6.4B Henry Ford, Beaumont Merger Failed on Cultural Hurdles
- House Lawmakers Grill CMS Over Health Exchange Navigators
- Fortunately, Angelina Jolie Isn't On Medicare
- Don't Let Nurses Sink Your Bottom Line
- Uncompensated Care Faces a Double Hit in Some States
- How Chargemaster Data May Affect Hospital Revenue
- Hospital Pricing Transparency a Marketing Game Changer
- Primary Care Docs Average More Hospital Revenue Than Specialists
- ED Physicians Key to Half of Hospital Admissions
- Hospitals Profit On Bloodstream Infections